Cannabis comp tables as of Oct. 1, 2019

This comp table provides a benchmark for private investors to evaluate existing and future investments as well as a menu for public investors to peruse.

Cannabis comp tables as of Sept. 23, 2019

This comp table provides a benchmark for private investors to evaluate existing and future investments as well as a menu for public investors to peruse.

Cannabis comp tables as of Sept. 17, 2019

This comp table provides a benchmark for private investors to evaluate existing and future investments as well as a menu for public investors to peruse.

Cannabis comp tables as of Sept. 9, 2019

This comp table provides a benchmark for private investors to evaluate existing and future investments and a menu for public investors to peruse.

Cannabis comp tables as of Sept. 2, 2019

This comp table provides a benchmark for private investors to evaluate existing and future investments and a menu for public investors to peruse.

Curaleaf expects margins over 30%, openings slow for iAnthus & more

Our key expectation for Curaleaf was for the guidance for 2020, as we last noted in our review of the Grassroots Cannabis deal, and Curaleaf did not disappoint.

Cannabis comp tables as of Aug. 26, 2019

This comp table provides a benchmark for private investors to evaluate existing and future investments and a menu for public investors to peruse.

Cannabis comp tables as of Aug. 19, 2019

This comp table provides a benchmark for private investors to evaluate existing and future investments and a menu for public investors to peruse.